Private company

Clarisonic

Brand of skin-care devices

Clarisonic is a brand of skin-care devices, primarily known for its sonic facial cleansing brushes, originally developed by Pacific Bioscience Laboratories of Redmond, Washington. The brand and its parent company were acquired by L'Oréal in 2011. In 2018, Clarisonic devices made up 14% of the skin care device market.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 20, 2026.

Overview

Jan 1, 2001Founded1

Clarisonic is a brand of skin-care devices, primarily known for its sonic facial cleansing brushes, originally developed by Pacific Bioscience Laboratories of Redmond, Washington. The brand and its parent company were acquired by L'Oréal in 2011. In 2018, Clarisonic devices made up 14% of the skin care device market. In July 2020, L'Oréal announced it would discontinue the Clarisonic brand and products, choosing instead to focus on other core business offerings. It is speculated that the actual cause was increasing competition from cheaper alternatives as the skin care device market grew.2

Corporate structure

Clarisonic is part of a group headed by L'Oréal. 215 entities, 44 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • L'Oréal Paris, France
    • Clarisonic Redmond
    • L'Oréal Sverige Bromma, Sweden
    • L'Oréal USA New York City, New York, United States
    • Sanofi Subsidiary · 9.43% · Paris, France
      • Hoechst 100% · Frankfurt am Main, Germany
      • Ablynx Ghent, Belgium
      • Sanofi (Belgium) Machelen, Belgium
      • Chattem Subsidiary · 100% · Chattanooga
      • Genzyme Subsidiary · 100% · Cambridge, Massachusetts, United States
        • GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP Subsidiary · Boston, Massachusetts, United States
      • Sanofi-Aventis Korea Subsidiary · 100% · Seoul, South Korea
      • Shantha Biotechnics Subsidiary · 98.7% · Medchal
      • Bioverativ Subsidiary · Waltham
      • Sanofi (Japan) Subsidiary · Tokyo, Japan
      • Sanofi Medley Subsidiary · Campinas, Brazil
      • Winthrop Subsidiary · United Kingdom
      • Zentiva Subsidiary · Praha 10, Czechia
      • SANOFI AVENTIS SA Subsidiary · 100% · Barcelona, Spain
      • SANOFI PASTEUR SA DE CV Subsidiary · 100% · Mexico City, Mexico
      • AZTECA VACUNAS SA DE CV Subsidiary · Mexico City, Mexico
      • Carraig Insurance Designated Activity Company Subsidiary · Dublin, Ireland
      • CHINOIN GYÓGYSZER-ÉS VEGYÉSZETI TERMÉKEK GYÁRA ZÁRTKÖRŰEN MŰKÖDŐ RT. Subsidiary · Budapest, Hungary
        • SANOFI-AVENTIS MAGYARORSZÁG KERESKEDELMI ÉS SZOLGÁLTATÓ ZÁRTKÖRŰEN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG Subsidiary · Budapest, Hungary
      • GENZYME FLANDERS Subsidiary · Geel, Belgium
      • HELVEPHARM AG Subsidiary · Vernier, Switzerland
      • Nattermann Verwaltungs GmbH Subsidiary · Frankfurt am Main, Germany
      • Opella Subsidiary · France
      • OPELLA HEALTHCARE AUSTRIA GMBH Subsidiary · Wien, Austria
      • OPELLA HEALTHCARE BELGIUM NV/SA Subsidiary · Machelen, Belgium
      • OPELLA HEALTHCARE POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Subsidiary · Warsaw, Poland
      • OPELLA HEALTHCARE SLOVAKIA S.R.O. Subsidiary · Bratislava, Slovakia
      • and 24 more
    • Aesop Subsidiary · Collingwood
    • Biotherm Subsidiary · Levallois-Perret
    • CeraVe Subsidiary
    • Garnier Subsidiary · Paris, France
    • Helena Rubinstein Subsidiary
    • IT Cosmetics Subsidiary · Jersey City, New Jersey, United States
    • Kiehl's Subsidiary · Third Avenue
    • L'Oréal Professionnel Subsidiary
    • La Roche-Posay Subsidiary
    • Lancôme Subsidiary · Courbevoie
    • Le Club des Créateurs de Beauté Subsidiary · Paris, France
    • Logona Subsidiary · Salzhemmendorf, Germany
    • Maison Margiela Subsidiary · Paris, France
    • Maybelline Subsidiary · New York City
    • Medik8 Subsidiary · Elstree and Borehamwood, United Kingdom
    • Niely Subsidiary
    • NYX Professional Makeup Subsidiary · El Segundo
    • Pureology Subsidiary
    • Sanoflore Subsidiary
    • Stylenanda Subsidiary · Seoul
    • Urban Decay Subsidiary · Roubaix
    • and 114 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

The story

Pacific Bioscience Laboratories was founded in 2001 by David Giuliani, Robb Akridge, Steve Meginniss, Ward Harris, and Ken Pilcher. Giuliani, Clarisonic's CEO, is the former co-founder and CEO of Optiva, which developed the Sonicare line of toothbrushes. Giuliani sold Optiva to Philips Oral Healthcare in 2000. Akridge was a scientist at Optiva Corporation before co-founding Clarisonic. He holds a bachelor's degree from University of Texas, a Master of Science degree in biology from Texas State University–San Marcos and a doctorate in microbiology from Texas A&M University. Ken Pilcher is the lead inventor of Clarisonic's skin care systems. In the past, he has developed avionics for the NASA Space Shuttle, as well as medical electronics. Clarisonic was backed by angel groups including Keiretsu Forum who provided the seed capital for the company.

Pacific Bioscience Laboratories launched its first sonic facial-cleansing brush under the Clarisonic brand in 2004, which was later known as the Mia 1. In 2012, the company launched the Mia 2, featuring two different oscillating speeds. The company introduced the Alpha Fit, a black model marketed toward men, in 2015. This was followed in early 2016 by the Mia Fit, a compact version of the original device. In September 2016, L'Oréal announced the elimination of 120 employees at the Clarisonic manufacturing facility in Redmond, Washington, and would begin to outsource production of the devices.

From Wikipedia’s article on Clarisonic, shared under CC BY-SA 4.0.3

Products and brands

  • cleanser
  • toner

Listed on Wikidata.1

Subsidiaries and ownership

Parent company

From Wikidata.1

Timeline

  1. Jan 1, 2001Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3